140 related articles for article (PubMed ID: 12973000)
1. FDG PET for imaging pericardial manifestations of Hodgkin lymphoma.
Buchmann I; Wandt H; Wahl A; Reske SN
Clin Nucl Med; 2003 Sep; 28(9):760-1. PubMed ID: 12973000
[TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW
Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of malignant pleural and pericardial disease on FDG PET/CT.
Makis W; Ciarallo A; Hickeson M; Rush C; Novales-Diaz JA; Derbekyan V; Laufer J; Stern J; Lisbona R
AJR Am J Roentgenol; 2012 Mar; 198(3):678-85. PubMed ID: 22358009
[TBL] [Abstract][Full Text] [Related]
4. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H
Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
7. A Case of Low-Grade Primary Cardiac Lymphoma with Pericardial Effusion Diagnosed by Combined 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) Imaging and Effusion Cytology.
Fukunaga H; Tatewaki Y; Mutoh T; Shimomura H; Yamamoto S; Terao C; Totsune T; Nakagawa M; Taki Y
Am J Case Rep; 2018 Mar; 19():292-295. PubMed ID: 29535291
[TBL] [Abstract][Full Text] [Related]
8. [Positron-emission tomography with fluorine-18-deoxyglucose in the staging and control of patients with lymphoma. Comparison with clinico-radiologic assessment].
Mainolfi C; Maurea S; Varrella P; Alaia C; Imparato C; Alfano B; Abate G; Bazzicalupo L
Radiol Med; 1998; 95(1-2):98-104. PubMed ID: 9636735
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
[TBL] [Abstract][Full Text] [Related]
10. Extranodal malignant lymphoma: detection with FDG PET versus CT.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Merkle E; Frickhofen N; Reske SN
Radiology; 1998 Feb; 206(2):475-81. PubMed ID: 9457202
[TBL] [Abstract][Full Text] [Related]
11. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
13. FDG PET in primary effusion lymphoma (PEL) of the pericardium.
Bhargava P; Glass E; Brown J; Eapen E; Ames E
Clin Nucl Med; 2006 Jan; 31(1):18-9. PubMed ID: 16374116
[No Abstract] [Full Text] [Related]
14. Enhanced CT and FDG PET/CT in Histiocytic Sarcoma of the Pericardium.
Dong A; Wang Y; Cui Y; Zuo C
Clin Nucl Med; 2016 Apr; 41(4):326-7. PubMed ID: 26545021
[TBL] [Abstract][Full Text] [Related]
15.
Aikawa T; Naya M; Oyama-Manabe N; Maekawa S; Nambu H; Mitsuyama H; Hirata K; Kanno-Okada H; Tsutsui H
J Nucl Cardiol; 2017 Jun; 24(3):1107-1109. PubMed ID: 27272149
[No Abstract] [Full Text] [Related]
16. FDG PET/CT Findings of Intracardiac Myeloid Sarcoma.
Niu N; Cui R; Li F
Clin Nucl Med; 2016 Mar; 41(3):235-6. PubMed ID: 26505855
[TBL] [Abstract][Full Text] [Related]
17. Fluorodeoxyglucose positron emission tomography excludes pericardial metastasis by recurrent lung cancer.
Ghesani NV; Sun X; Zhuang H; Sam JW; Alavi A
Clin Nucl Med; 2003 Aug; 28(8):666-7. PubMed ID: 12897654
[TBL] [Abstract][Full Text] [Related]
18. Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031.
McCarten KM; Metzger ML; Drachtman RA; Pei Q; Friedman DL; Schwartz CL; Kelly KM
Pediatr Radiol; 2018 Nov; 48(12):1736-1744. PubMed ID: 30014200
[TBL] [Abstract][Full Text] [Related]
19. A case of primary pericardial mesothelioma detected by 18F-FDG PET/CT.
Aga F; Yamamoto Y; Norikane T; Nishiyama Y
Clin Nucl Med; 2012 May; 37(5):522-3. PubMed ID: 22475912
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]